NAD+ and Longevity: Complete Research Review

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every living cell, essential for hundreds of metabolic reactions. Its role in longevity research has made it one of the most studied molecules in ageing biology.

Fundamental functions of NAD+: - Electron carrier in mitochondrial oxidative phosphorylation (energy production) - Substrate for sirtuins (SIRT1-7), a family of NAD+-dependent deacylases - Substrate for PARPs (poly-ADP-ribose polymerases), critical for DNA repair - Substrate for CD38/CD157, involved in immune cell signalling - Regulator of circadian rhythm through CLOCK-BMAL1 pathway

The NAD+ decline with age: One of the most consistent findings in ageing research is that NAD+ levels decline with age across multiple tissues and species. This decline has been observed in human blood, muscle, brain, and liver tissue. By age 50, NAD+ levels may be approximately 50% of those at age 20.

Why this matters: The age-related decline in NAD+ affects all NAD+-dependent processes simultaneously: energy production, DNA repair, gene regulation, and immune function. Restoring NAD+ levels has become a central strategy in longevity research.

ORYN offers NAD+ as pre-filled pens and NovaDose cartridges. >99% purity, GMP certified. For research purposes only.

Sirtuins are a family of seven NAD+-dependent enzymes (SIRT1-7) that regulate gene expression, metabolic pathways, and stress responses. They are often called longevity genes due to their association with lifespan extension in model organisms.

Key sirtuins in longevity research: - SIRT1: Nuclear sirtuin that deacetylates histones and transcription factors. Involved in glucose metabolism, fat mobilisation, stress resistance, and circadian rhythm regulation - SIRT3: Mitochondrial sirtuin that regulates oxidative phosphorylation, ROS detoxification, and fatty acid oxidation. Critical for mitochondrial health - SIRT6: Nuclear sirtuin involved in DNA repair, telomere maintenance, and glucose homeostasis. SIRT6 overexpression has extended lifespan in mouse models

NAD+ as the limiting factor: Sirtuins require NAD+ as a co-substrate for their enzymatic activity. As NAD+ declines with age, sirtuin activity decreases proportionally. This creates a cascade effect: reduced sirtuin activity leads to impaired gene regulation, increased inflammation, metabolic dysfunction, and accumulated DNA damage.

Research implications: Restoring NAD+ levels could theoretically reactivate sirtuin-mediated protective pathways. This hypothesis has driven extensive research into NAD+ supplementation strategies, including direct NAD+ administration, NMN (nicotinamide mononucleotide), and NR (nicotinamide riboside).

All ORYN NAD+ products are for research purposes only.

NAD+ plays a critical role in maintaining genomic stability through its function as a substrate for PARP enzymes, which are central to DNA repair processes.

PARPs and DNA repair: - PARP1 is one of the first responders to DNA strand breaks - Upon detecting damage, PARP1 consumes NAD+ to produce poly-ADP-ribose chains that recruit repair machinery - PARP1 activity accounts for a significant proportion of cellular NAD+ consumption - With age, accumulated DNA damage increases PARP activity, further depleting NAD+ reserves

The NAD+-DNA repair connection: Research has revealed a critical feedback loop: ageing increases DNA damage, which increases PARP activity, which depletes NAD+, which reduces sirtuin activity and other protective mechanisms, which accelerates further DNA damage. Breaking this cycle through NAD+ replenishment is a key research strategy.

Published evidence: - NAD+ supplementation in aged mice improved DNA repair capacity (Science, 2017) - PARP inhibition combined with NAD+ precursor supplementation showed synergistic effects on DNA repair in preclinical models - Human studies have shown correlations between NAD+ levels and DNA damage markers

Telomere connections: SIRT6, which requires NAD+ for activity, is directly involved in telomere maintenance. NAD+ depletion impairs SIRT6 function, potentially contributing to telomere shortening and cellular senescence.

ORYN NAD+ pens provide >99% purity for high-quality research. GMP certified, COA included.

NAD+ is indispensable for mitochondrial function, serving as the primary electron carrier in the electron transport chain where most cellular ATP is produced.

NAD+ in mitochondrial metabolism: - Accepts electrons from metabolic substrates in the TCA cycle (as NAD+) and donates them to Complex I of the electron transport chain (as NADH) - The NAD+/NADH ratio is a key regulator of metabolic flux - Mitochondrial SIRT3 uses NAD+ to regulate multiple TCA cycle enzymes and electron transport chain components - NAD+ depletion impairs mitochondrial membrane potential and ATP production

Age-related mitochondrial decline: Mitochondrial dysfunction is a hallmark of ageing. Research has shown that: - NAD+ levels in muscle mitochondria decline significantly with age - This decline correlates with reduced oxidative phosphorylation capacity - Restoring NAD+ in aged mice improved mitochondrial function and exercise capacity - SIRT1-mediated mitochondrial biogenesis (via PGC-1alpha) is NAD+-dependent

Research on NAD+ supplementation and mitochondria: Preclinical studies in aged mice have demonstrated that NAD+ replenishment can: - Restore mitochondrial membrane potential - Improve respiratory chain function - Enhance exercise endurance - Promote mitochondrial biogenesis through SIRT1/PGC-1alpha activation

ORYN offers NAD+ in pen and NovaDose cartridge formats for research applications. >99% purity, GMP manufactured.

The choice of NAD+ delivery method significantly impacts bioavailability and research outcomes. Understanding the advantages and limitations of each approach is essential for designing rigorous protocols.

Direct NAD+ administration (subcutaneous): - Bypasses the oral absorption and hepatic first-pass challenges - Higher bioavailability compared to oral NAD+ precursors - More controlled dosing with pre-filled pens (under 2% variance) - ORYN NAD+ pens deliver direct NAD+ via subcutaneous route

Oral NAD+ precursors (NMN, NR): - NMN and NR are converted to NAD+ through different metabolic pathways - Oral bioavailability varies significantly between individuals - May be subject to hepatic first-pass metabolism - Conversion efficiency to NAD+ is not 100%

IV NAD+ infusion: - Highest immediate bioavailability but impractical for regular research use - Requires clinical setting and medical supervision - Significant time commitment per session (2-4 hours) - Cost-prohibitive for most research applications

Why ORYN pens for NAD+ research: - Pre-filled format eliminates reconstitution variability - Dosing precision under 2% for reproducible results - >99% purity verified by HPLC - GMP manufacturing ensures batch consistency - COA included with each shipment - EU shipping, 3-5 day delivery, free over EUR175

All ORYN NAD+ products are for research purposes only.